ATE866T1 - Immunserumglobulin (isg)-praeparate und verfahren zu ihrer herstellung. - Google Patents

Immunserumglobulin (isg)-praeparate und verfahren zu ihrer herstellung.

Info

Publication number
ATE866T1
ATE866T1 AT79103152T AT79103152T ATE866T1 AT E866 T1 ATE866 T1 AT E866T1 AT 79103152 T AT79103152 T AT 79103152T AT 79103152 T AT79103152 T AT 79103152T AT E866 T1 ATE866 T1 AT E866T1
Authority
AT
Austria
Prior art keywords
globulin
immune
isg
germinal
preparations
Prior art date
Application number
AT79103152T
Other languages
English (en)
Inventor
John L. Lundblad
Willis L. Warner
Peter M. Fernandes
Original Assignee
Cutter Laboratories, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25517325&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE866(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cutter Laboratories, Inc. filed Critical Cutter Laboratories, Inc.
Application granted granted Critical
Publication of ATE866T1 publication Critical patent/ATE866T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591—Stabilisation, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT79103152T 1978-12-18 1979-08-27 Immunserumglobulin (isg)-praeparate und verfahren zu ihrer herstellung. ATE866T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/970,686 US4186192A (en) 1978-12-18 1978-12-18 Stabilized immune serum globulin
EP79103152A EP0012156B1 (de) 1978-12-18 1979-08-27 Immunserumglobulin (ISG)-Präparate und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ATE866T1 true ATE866T1 (de) 1982-05-15

Family

ID=25517325

Family Applications (1)

Application Number Title Priority Date Filing Date
AT79103152T ATE866T1 (de) 1978-12-18 1979-08-27 Immunserumglobulin (isg)-praeparate und verfahren zu ihrer herstellung.

Country Status (7)

Country Link
US (1) US4186192A (de)
EP (1) EP0012156B1 (de)
JP (1) JPS5583711A (de)
AT (1) ATE866T1 (de)
CA (1) CA1117417A (de)
DE (1) DE2962569D1 (de)
MX (1) MX6015E (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3176491D1 (en) * 1980-03-05 1987-11-26 Miles Lab Pasteurized therapeutically active protein compositions
US4396608A (en) * 1981-08-24 1983-08-02 Cutter Laboratories Intravenously injectable immune serum globulin
US4478829A (en) * 1983-04-28 1984-10-23 Armour Pharmaceutical Company Pharmaceutical preparation containing purified fibronectin
US4617379A (en) * 1983-06-14 1986-10-14 Miles Laboratories, Inc. High titer cytomegalovirus immune serum globulin
SE456136B (sv) * 1985-06-17 1988-09-12 Oncholab Ab Forfarande for framstellning av en med ett lipofilt biologiskt aktivt emne bemengd berare pa basis av rekonstituerat ldl (lagdensitetslipoprotein)
US4665159A (en) * 1985-11-07 1987-05-12 Miles Laboratories, Inc. High titer varicella-zoster immune globulin for intravenous administration
US4717564A (en) * 1985-11-07 1988-01-05 Miles Laboratories, Inc. High titer varicella-zoster immune globulin for intravenous administration
US4717766A (en) * 1986-01-27 1988-01-05 Miles Laboratories, Inc. Method of preparing high titer anti-respiratory syncytial virus intravenous immune globulin
US4659563A (en) * 1986-01-27 1987-04-21 Miles Laboratories, Inc. High titer anti-respiratory syncytial virus intravenous immune globulin
US4911910A (en) * 1986-11-25 1990-03-27 Biotech Research Labs, Inc. Purified equine immunologlobulins and method of use thereof
US5237054A (en) * 1987-02-20 1993-08-17 Akzo Pharma Stabilized aqueous composition containing antibodies
US5472702A (en) * 1987-08-26 1995-12-05 United States Surgical Corporation Sterilization of growth factors
JPH03504605A (ja) * 1988-05-27 1991-10-09 セントカー・インコーポレーテツド 抗体産生物の凍結乾燥した配合物
US5221616A (en) * 1988-07-15 1993-06-22 Quidel Corporation Prevention of spontaneous complement activation in mammalian biological fluids
DE4001451A1 (de) * 1990-01-19 1991-08-01 Octapharma Ag Stabile injizierbare loesungen von faktor viii und faktor ix
US5945098A (en) * 1990-02-01 1999-08-31 Baxter International Inc. Stable intravenously-administrable immune globulin preparation
JPH04112544U (ja) * 1990-08-31 1992-09-30 三洋電機株式会社 防水型電話機
DE4344824C1 (de) * 1993-12-28 1995-08-31 Immuno Ag Hochkonzentriertes Immunglobulin-Präparat und Verfahren zu seiner Herstellung
DE4424935C1 (de) * 1994-07-14 1996-03-21 Immuno Ag Humanes virussicheres monomeres Immunglobulin A und Verfahren zu seiner Herstellung
US6962700B1 (en) * 2000-09-13 2005-11-08 Atopix Pharmaceuticals Corporation Method of manufacturing immune globulin
SI1475101T1 (sl) * 2002-02-14 2011-03-31 Chugai Pharmaceutical Co Ltd Farmacevtski proizvodi iz raztopine, ki vsebuje protitelo
EP1532983A1 (de) 2003-11-18 2005-05-25 ZLB Bioplasma AG Immunoglobulinpräparationen mit erhöhter Stabilität
TWI532498B (zh) 2008-03-17 2016-05-11 巴克斯特保健公司 供免疫球蛋白及玻尿酸酶之皮下投藥之用的組合及方法
WO2011034604A2 (en) 2009-09-17 2011-03-24 Baxter Healthcare, S.A. Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereof
AU2011212440B2 (en) 2010-02-04 2015-01-22 Csl Behring Ag Immunoglobulin preparation
EP2361636A1 (de) 2010-02-26 2011-08-31 CSL Behring AG Immunglobulinpräparat und Aufbewahrungssystem für ein Immunglobulinpräparat

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB550224A (en) * 1940-08-01 1942-12-30 Lederle Lab Inc Improvements in the preservation of dried blood grouping serum
US3903262A (en) * 1972-03-13 1975-09-02 Cutter Lab Pharmaceutical compositions comprising intravenously injectable modified serum globulin, its production and use
DE2653534C2 (de) * 1975-12-22 1986-08-28 Baxter Travenol Laboratories, Inc., Deerfield, Ill. Feste Antihämophilen-Faktor-Präparation und Verfahren zu ihrer Herstellung
US4089944A (en) * 1975-12-22 1978-05-16 Baxter Travenol Laboratories, Inc. Rapidly solubilized AHF composition and process for preparing same
JPS5347515A (en) * 1976-10-13 1978-04-28 Green Cross Corp:The Gamma-globulin pharmaceutical preparation for intravenous injection
JPS5420124A (en) * 1977-07-14 1979-02-15 Green Cross Corp:The Preparation of gamma-globulin intravenous injection

Also Published As

Publication number Publication date
EP0012156A1 (de) 1980-06-25
EP0012156B1 (de) 1982-04-21
DE2962569D1 (en) 1982-06-03
US4186192A (en) 1980-01-29
MX6015E (es) 1984-09-24
CA1117417A (en) 1982-02-02
JPS5583711A (en) 1980-06-24
JPH0232261B2 (de) 1990-07-19

Similar Documents

Publication Publication Date Title
ATE866T1 (de) Immunserumglobulin (isg)-praeparate und verfahren zu ihrer herstellung.
DD129788A5 (de) Verfahren zur herstellung von 3',3'',5',5''-tetrachlorphenol-3,4,5,6-tetrabromsulfophthalein bzw.3',3''-dibrom-5',5''-dichlorphenol-3,4,5,6-tetrachlorsulfophthalein
IT7924131A0 (it) Gasolio. processo per la preparazione di
DE3886213D1 (de) Verfahren zur Herstellung von Antioxidant-Zubereitungen.
CH393349A (de) Verfahren zur Herstellung von Pyrazolo-(1',5' :3,2)-chinazolonen
GB2032437B (en) Method for the preparation of an immune globulin solution suitable for intravenous use
ATE3411T1 (de) Verfahren zur herstellung von 2,6dialkylcyclohexylaminen.
IT7926729A0 (it) Procedimento per la preparazione di coloranti cianazoici.
PT70398A (de) Verfahren zur herstellung von 1,2,3-thiadiazol-5-yl-harnstoffen
DD136832A5 (de) Verfahren zur herstellung von 1,2-dichloraethan
SE7907986L (sv) Sett att framstella 3alfa,7beta-dihydroxicholansyra
AT344885B (de) Verfahren zur herstellung von 18-arabinosyl-2-n-butyl-3,7,11,15,19,21,23,25,27,37-dekahydroxy-4,16,32,34,36-pentamethyl-tetrakonta-16,32-dien-35-o-lacton-40-guanidiniumsulfat(debrycin) enthaltenden pharmazeutischen praeparaten
DD132495A5 (de) Verfahren zur herstellung von 6a,10a-cis-hexahydrodibenzopyranonen
ATE1239T1 (de) Verfahren zur herstellung von 4-amino-5-chlor-1-phenyl-pyridazon-(6).
EP0011843A3 (en) Developing components for hair oxydation dyes, their preparation and hair dyes containing them
ATE16800T1 (de) Verfahren zur herstellung von 2,4-diamino-(3,5dimethoxy-4-methoxy-ethoxy-benzyl)-pyrimidin.
RO76177A (ro) Procedeu pentru prepararea octahidro-indolo-2,3-a/chinolizine-1,1-disubstituite
ATE4207T1 (de) Verfahren zur herstellung von l-asparaginsaeure-n- thiocarboxyanhydrid.
ATA45378A (de) Verfahren zur herstellung von cyclohexandion- (1,4)-tetramethyldiketal
PT70497A (de) Verfahren zur herstellung von 5-mercapto-1,2,3-triazolen
PT70178A (de) Verfahren zur herstellung von 1,2,3-thiadiazol-5-yl-harnstoffen
DE2961506D1 (en) N-cyclohexyl-n-methoxy-acetoacetamide, process for its preparation and its use to prepare o-methyl-n-cyclohexyl-2,5-dimethyl-furane-3-hydroxamic acid
DD130251A5 (de) Verfahren zur herstellung von 6 beta,7-methylen-3-oxo-4-en-steroiden
DD128359A5 (de) Verfahren zur herstellung von 5,6-dehydropenicillinen
DD132497A1 (de) Verfahren zur herstellung von neuen gona-4,9(10)-dienen

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
EELA Cancelled due to lapse of time